المؤلفون: Davis LN; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Walker ZJ; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Reiman LT; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Parzych SE; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Stevens BM; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Jordan CT; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Forsberg PA; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Sherbenou DW; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.; University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jul 15; Vol. 30 (14), pp. 3023-3035.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/drug therapy , Multiple Myeloma*/pathology , Multiple Myeloma*/immunology , CD8-Positive T-Lymphocytes*/immunology , CD8-Positive T-Lymphocytes*/drug effects , CD8-Positive T-Lymphocytes*/metabolism , Proto-Oncogene Proteins c-myc*/genetics , Proto-Oncogene Proteins c-myc*/metabolism , Drug Resistance, Neoplasm* , Ikaros Transcription Factor*/metabolism , Ikaros Transcription Factor*/genetics , Thalidomide*/analogs & derivatives , Thalidomide*/pharmacology , Immunomodulating Agents*/pharmacology , Interferon Regulatory Factors*/metabolism , Interferon Regulatory Factors*/genetics, Humans ; Cell Line, Tumor ; Lenalidomide/pharmacology ; Lenalidomide/therapeutic use ; Gene Expression Regulation, Neoplastic/drug effects ; Female ; Male

المؤلفون: Keller AL; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Reiman LT; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Perez de Acha O; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Parzych SE; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Forsberg PA; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado., Kim PS; Sanofi R&D, North America, Cambridge, Massachusetts., Bisht K; Sanofi R&D, North America, Cambridge, Massachusetts., Wang H; Sanofi R&D, North America, Cambridge, Massachusetts., van de Velde H; Oncology Development, Sanofi, Brussels, Belgium., Sherbenou DW; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

المصدر: Cancer research communications [Cancer Res Commun] 2024 Mar 12; Vol. 4 (3), pp. 757-764.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/drug therapy , Antineoplastic Agents*/therapeutic use , Antibodies, Monoclonal*, Humans ; T-Lymphocytes ; B-Cell Maturation Antigen/therapeutic use ; ADP-ribosyl Cyclase 1 ; Neoplasm Recurrence, Local/drug therapy

المؤلفون: Perez de Acha O; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Reiman L; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Jayabalan DS; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York-Presbyterian, New York City, NY., Walker ZJ; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Bosma G; Department of Biostatistics and Informatics, Center for Innovative Design and Analysis, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO., Keller AL; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Parzych SE; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Abbott D; Department of Biostatistics and Informatics, Center for Innovative Design and Analysis, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO., Idler BM; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Ribadeneyra D; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York-Presbyterian, New York City, NY., Niesvizky R; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York-Presbyterian, New York City, NY., Forsberg PA; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Mark TM; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Sherbenou DW; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO.; University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, CO.

المصدر: Blood advances [Blood Adv] 2023 Nov 14; Vol. 7 (21), pp. 6430-6440.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/metabolism, Humans ; ADP-ribosyl Cyclase 1 ; Antibodies, Monoclonal/pharmacology ; Antibodies, Monoclonal/therapeutic use ; Retrospective Studies